Nonautonomous effects of oncogenic YAP in hepatocarcinogenesis
2017
Authors: Marquard S, Thomann S, Weiler SME, Sticht C, Gretz N, Schirmacher P, Breuhahn K
CellNetworks People: Schirmacher Peter
Journal: Pathologe. 2017 Oct 10. doi: 10.1007/s00292-017-0361-2.

BACKGROUND:

The transcriptional coactivator yes-associated protein (YAP) is a strong oncogene in liver cancer development.
OBJECTIVES:

To investigate if and how YAP-induced paracrine-acting factors are regulated in hepatocytes and liver cancer cells.
MATERIAL AND METHODS:

Transcriptome analysis and proteomics of murine wildtype and YAP-transgenic hepatocytes were performed to identify paracrine-acting proteins. Molecular and biochemical techniques were used to examine the mechanisms of YAP-dependent gene regulation. Gene expression data from HCC (hepatocellular carcinoma) patients was evaluated.
RESULTS:

Several YAP-dependent, secreted factors (e. g. CXCL10, GDF15, PDGFB) were identified. YAP regulates these factors through transcription factors of the TEAD (TEA domain) protein family. Moreover, the dysregulation of the YAP-target genes is often associated with poor HCC patient prognosis.
CONCLUSIONS:

YAP induces the expression of paracrine-acting factors that may affect the tumor microenvironment and therefore support carcinogenesis. This multicellular network could allow the development of novel and specific perturbation approaches.